.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cholestatic liver diseases (CLD), such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), significantly impair patient quality of life. These conditions often lead to debilitating sickness-behavior symptoms, including chronic fatigue, cognitive decline, and anxiety. Recent neuroimaging studies have highlighted structural changes in the thalamus of these patients. Importantly, research suggests that TNF neutralization cholestasis thalamus pathways may be central to managing these neurological complications. Researchers are now exploring how systemic inflammation directly alters brain transcriptomics.
A recent study utilized a bile duct ligation (BDL) mouse model to investigate the mechanistic link between liver injury and brain health. MRI analysis revealed that BDL mice suffered from reduced thalamic volume compared to healthy controls. Furthermore, RNA-seq transcriptomic signatures indicated a massive shift in molecular activity. These changes suggested the inhibition of cellular growth, impaired neurite formation, and enhanced apoptosis within the thalamus. Consequently, these structural and functional alterations likely drive the behavioral symptoms observed in clinical settings.
Systemic TNF acts as a primary regulator of liver-to-brain communication. Therefore, scientists administered anti-TNF antibodies to neutralize systemic TNF in the BDL model. This intervention yielded significant results, as the therapy effectively attenuated the BDL-associated transcriptomic changes. Specifically, TNF inhibition enhanced gene expression in pathways dedicated to neurotransmission and neuron survival. While myelination pathways remained largely unchanged, the overall structural machinery showed remarkable recovery. Resultantly, this suggests that targeting TNF may represent a novel approach to treat the neurological burden of liver disease.
Currently, treatment options for the fatigue and cognitive symptoms associated with CLD remain limited. However, this study provides a molecular foundation for the use of TNF inhibitors in a hepatology context. Notably, neutralizing systemic inflammation might prevent the progressive thalamic atrophy that correlates with symptom severity. Clinicians should monitor emerging data on biological therapies that bridge the gap between systemic inflammation and central nervous system health.
Cholestasis triggers systemic inflammation, specifically increasing TNF levels. These cytokines cross or communicate through the blood-brain barrier, altering the transcriptomic signature of the thalamus and disrupting neural signaling, which leads to fatigue and cognitive impairment.
According to recent research, TNF neutralization significantly improves pathways related to neurotransmission and neuron survival. However, some changes, such as alterations in myelination pathways, may remain unaffected by this specific intervention.
No, anti-TNF therapy for fatigue in PBC or PSC is currently in the experimental and research stages. While mouse models show promise, clinical trials are necessary to determine safety and efficacy in human populations.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research identifies how TNF neutralization mitigates thalamic transcriptomic changes in cholestatic liver injury, potentially addressing fatigue symptom...
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
